MedTrace Logo

Combined Vitrectomy and Femtosecond Laser-assisted Cataract Surgery

NCT05588037 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-10-20

No results posted yet for this study

Summary

Based on the progress of cataract surgery, intraocular lens development, vitreoretinal surgery and anesthesia technology in recent years, the purpose of this study is to develop a new type of more accurate and minimally invasive combined surgery for cataract and fundus diseases, and to evaluate the advantages and value of the surgery as well as related complications, so as to minimize the surgical trauma and obtain faster visual function recovery and better patient comfort. To provide new solutions for the growing demand of eye health care.

Conditions

  • Macular Disease
  • Rhegmatogenous Retinal Detachment
  • Epiretinal Membrane
  • Cataract
  • Vitreous Hemorrhage
  • Vitreomacular Traction
  • Vitreous Cloudy

Interventions

PROCEDURE

FLACS +PPV+IOL + air

The procedures are combined the FLACS +PPV+IOL + air.

PROCEDURE

FLACS +PPV+IOL + epiretinal membrane peeling + Ozurdex

The procedures are combined the FLACS +PPV+IOL + epiretinal membrane peeling + Ozurdex.

PROCEDURE

FLACS + PPV+IOL + internal limiting membrane peeling + air

The procedures are combined the FLACS + PPV+IOL + internal limiting membrane peeling + air.

PROCEDURE

FLACS + PPV+IOL

The procedures are combined the FLACS + PPV+IOL.

Sponsors & Collaborators

  • Aier School of Ophthalmology, Central South University

    lead OTHER

Principal Investigators

  • Wensheng Li · Aier Ophthalmology School of Central South University; Shanghai Aier Eye Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05588037 on ClinicalTrials.gov